← SynDRA
CGH-2466
SynDRA canonical compound SYN0078838 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | ADORA1 | ADORA2B | ADORA3 |
| Mechanism of action | adenosine receptor antagonist |
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CYP3A4
- TLK1
- BAZ2B
- CBX1
- GMNN
- IKBKB
- JAK2
- KDM4A
- PRKCB
- PRKCQ
- RAF1
- SMAD3
- SMPD1
- TDP1
- UBE2N
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- BARD1
- BRCA1
- CP2C9
- CP3A7
- GNA15
- IL1B
- KSYK
- MDM2
- MDM4
- NSD2
- SYK
- TAAR1
Cross-references
Synonyms
- CGH 2466
- 4-(3,4-Dichlorophenyl)-5-(4-pyridinyl)-2-thiazolamine
- 4-(3,4-Dichlorophenyl)-5-(pyridin-4-yl)thiazol-2-amine
- 4-(3,4-dichlorophenyl)-5-pyridin-4-yl-1,3-thiazol-2-amine
- C14128
- AC1NQZWM
- CTK8E9516
- LS-192831
- SCHEMBL1223368
- SCHEMBL29394682
- CHEBI:34599
- 4-(3,4-DICHLOROPHENYL)-5-(PYRIDIN-4-YL)-1,3-THIAZOL-2-AMINE
- NCGC00092379-02
- DB-395493
- BRD-K82028950-300-01-1
- BRD-K82028950-300-02-9
- 4-(3,4-dichlorophenyl)-5-(4-pyridyl)thiazol-2-amine
- EX-A14428
- CGH2466
- Cgh 2466 dihydrochloride
- MS-33282
- AKOS024457061
- CGH2466 (dihydrochloride)
- HY-103167
- NCGC00092379-01
- SCHEMBL16102298
- CGH2466 dihydrochloride
Look up CGH-2466 in the interactive SynDRA portal →